SIRT1 increased with exercise with associated improvement in NAFLD and its markers (Ghareghani et al., 2018[41]) via inhibition of NF-κB and CD36 (Niu et al., 2018[107]). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.